Stock comparison
AGILENT TECHNOLOGIES, INC. is 30.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.95 B vs $1.23 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
A is larger
AGILENT TECHNOLOGIES, INC. is 30.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.95 B vs $1.23 B).
Market value leader
A
AGILENT TECHNOLOGIES, INC. is 30.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.95 B vs $1.23 B).
Revenue leader
A
EYPT: $31.37M vs A: $6.95B.
Profit leader
A
EYPT: -$231.96M vs A: $1.30B.
Margin leader
A
EYPT: -739.4% vs A: 18.8% net margin.
| Metric | EYPT | A |
|---|---|---|
| Market cap | $1.23 B | $37.95 B |
| US-listed rank | #2502 | #404 |
| Revenue (latest FY) | $31.37M | $6.95B |
| Net income (latest FY) | -$231.96M | $1.30B |
| Net margin | -739.4% | 18.8% |
| P/E (trailing FY) | - | 29.1x |
| SEC filings | 1,308 | 2,339 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AGILENT TECHNOLOGIES, INC. is 30.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.95 B vs $1.23 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: EyePoint Pharmaceuticals, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.